Monitoring adherence and defaulting for antiretroviral therapy in 5 east African countries: An urgent need for standards

Journal of the International Association of Physicians in AIDS Care

Volumn 7, Issue 4, 2008, Pages 193-199

  Chalker, John ^a   Andualem, Tenaw ^b   Minzi, Omary ^c   Ntaganira, Joseph ^d   Ojoo, Atieno ^e   Waako, Paul ^f   Ross Degnan, Dennis ^g  

^a MANAGEMENT SCIENCES FOR HEALTH   (United States)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d UNIVERSITY OF RWANDA   (Rwanda)

^e KENYATTA NATIONAL HOSPITAL   (Kenya)

^f MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

adherence; antiretroviral medications; defaulting; East Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AFRICA; ARTICLE; CHILD; EPIDEMIOLOGY; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; PATIENT COMPLIANCE; QUESTIONNAIRE; STANDARD; STATISTICS; TREATMENT OUTCOME; VIROLOGY;

ADULT; AFRICA, EASTERN; ANTI-HIV AGENTS; CHILD; HEALTH CARE SURVEYS; HIV INFECTIONS; HIV-1; HUMANS; INTERVIEWS AS TOPIC; PATIENT COMPLIANCE; PROGRAM EVALUATION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 59049083724     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109708320687     Document Type: Article

References (23)

1. Arnsten JH, Demas PA, Farzadegan H., et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001 ; 33: 1417-1423. (Pubitemid 32955198)
2. Paterson DL, Swindells S., Mohr J., et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 ; 133: 21-30. (Pubitemid 30432540)
3. Smith R. Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges ? Proc R Soc Lond B. 2006 ; 273: 617-624. (Pubitemid 46768067)
4. DiMatteo MR Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004 ; 42: 200-209.
5. Osterberg L., Blaschke T. Adherence to medication. New Engl J Med. 2005 ; 353: 487-497. (Pubitemid 41127293)
6. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005 ; 19: 1243-1249. (Pubitemid 41224892)
7. Ferradini L., Jeannin A., Pinoges L., et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006 ; 367: 1335-1342.
8. Wools-Kaloustian K., Kimaiyo S., Diero L., et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS. 2006 ; 20: 41-48. (Pubitemid 41818113)
9. van Oosterhout JJ, Bodasing N., Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005 ; 10: 464-470. (Pubitemid 40712431)
10. Simoni JM, Frick PA, Pantalone DW, Turner BJ Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003 ; 11: 185-198.
11. Ammassari A., Trotta MP, Murri R., et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002 ; 31 (suppl 3). S123 - S127.
12. UNAIDS/MEASURE. National AIDS Programmes: A Guide to Monitoring and Evaluation. Geneva, Switzerland: UNAIDS ; 2000. UNAIDS/00.17E. 2000.
13. World Health Organization. The Monitoring and Evaluation (M&E) of the 3 by 5 Initiative. Geneva, Switzerland: World Health Organization ; 2003. WHO/ HIV/2003.11. 2003.
14. HIVpolicy.org. The Global Fund to fight AIDS, Tuberculosis and malaria (2001-). Monitoring and evaluation toolkit: HIV/AIDS, tuberculosis, and malaria. 2004. http://www.hivpolicy.org/biogs/HPE0209b.htm. Updated May 5, 2008. Accessed June 3, 2008.
15. Global AIDS Program. Monitoring and Evaluation Capacity Building for Program, Improvement Field Guide, Version 1. Atlanta, GA: US Centers for Disease Control and Prevention ; 2003.
16. Office of the United States Global AIDS coordinator. The President's Emergency Plan for AIDS Relief: U.S. Five-Year Global HIVAIDS Strategy. 23-2-2004. Washington, DC: United States Global AIDS Coordinator ; 2004.
17. Rehle T., Saidel T., Mills S., Magnani R., Rodgers AB Evaluating Programs for HIV/AIDS Prevention and Care in Developing Countries. A Handbook for Program Managers and Decision Makers. Arlington, VA: Family Health International's Implementing AIDS prevention and care (IMPACT) project ; 2001.
18. Nairobi M. & E. Network, African Evaluation Association Secretariat, Rseau Nigrian de Suivi et Evaluation, Cape Verde Evaluation Network, Rseau Malagache de Suivi et Evaluation (Madagascar), and Eritrean Evaluation Network. The African Evaluation Guidelines 2000: A check-list to assist evaluators, Draft 1.4. http://www.geocities.com/afreval/documents/aeg.htm. Published January 2001. Accessed June 3, 2008.
19. Liu H., Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001 ; 134: 968-977. (Pubitemid 32466236)
20. Nieuwkerk PT, Oort FJ Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005 ; 38: 445-448. (Pubitemid 40381555)
21. van Oosterhout JJ, Bodasing N., Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005 ; 10: 464-470. (Pubitemid 40712431)
22. Fairley CK, Permana A., Read TR Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med. 2005 ; 6: 366-369. (Pubitemid 41335147)
23. WHO/DAP. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. 1-87. Geneva, Switzerland: World Health Organization ; 1993.